Abstract
We report here on a preliminary investigation of ganglioside composition and structure in human hemangioma, a benign tumor in the frontal cortex (HFC) in comparison to normal frontal cortex (NFC) tissue using for the first time advanced mass spectrometric methods based on fully automated chip-nanoelectrospray (nanoESI) high-capacity ion trap (HCT) and collision-induced dissociation (CID). The high ionization efficiency, sensitivity and reproducibility provided by the chip-nanoESI approach allowed for a reliable MS-based ganglioside comparative assay. Unlike NFC, ganglioside mixture extracted from HFC was found dominated by species of short glycan chains exhibiting lower overall sialic acid content. In HFC, only GT1 (d18:1/20:0), and GT3 (d18:1/25:1) polysialylated species were detected. Interestingly, none of these trisialylated forms was detected in NFC, suggesting that such components might selectively be associated with HFC. Unlike the case of previously investigated high malignancy gliosarcoma, in HFC one modified O-Ac-GD2 and one modified O-Ac-GM4 gangliosides were observed. This aspect suggests that these O-acetylated structures could be associated with cerebral tumors having reduced malignancy grade. Fragmentation analysis by CID in MS2 mode using as precursors the ions corresponding to GT1 (d18:1/20:0) and GD1 (d18:1/20:0) provided data corroborating for the first time the presence of the common GT1a and GT1b isomers and the incidence of unusual GT1c and GT1d glycoforms in brain hemangioma tumor.
Similar content being viewed by others
References
Siegel AM (1998) Acta Neurol Scand 98:369–371
Pozzati E, Acciarri N, Tognetti F, Marliani F, Giangaspero F (1996) Neurosurgery 38:662–670
Houtteville JP (1997) Surg Neurol 48:610–614
Detweiler PW, Porter RW, Zabramski JM, Spetzler RF (1997) J Neurosurg 87:629–632
Dorner L, Buhl R, Hugo HH, Jansen O, Barth H, Mehdorn HM (2005) Acta Neurochir 147:1091–1096
Mosnier JF, Brunon J, Nuti C (2007) Neurochirurgie 53:131–135
Lehnhardt FG, von Smekal U, Rűckriem B, Stenzel W, Neveling M, Heiss WD, Jacobs AH (2005) Arch Neurol 62:653–658
Ledeen RW, Yu RK (1982) Methods Enzymol 83:139–191
Fishman PH, Brady RO (1976) Science 194:906–915
Ledeen RW J (1978) Supramol Struct 8:1–17
Ledeen RW, Yu RK (1982) Methods Enzymol 83:109–191
Yu RK, Macala LJ, Taki T, Weinfeld HM, Yu FS (1988) J Neurochem 50:1825–1829
Yu RK (1994) Prog Brain Res 101:31–44
Hakomori S (2000) Glycoconj J 17:627–647
Ledeen RW, Wu G (2002) Neurochem Res 27:637–647
Ziche M, Alessandri G, Gullino PM (1989) Lab Invest 61:629–634
Alessandri G, Kaju KS, Gullino PM (1986) Inv Metast 6:145–165
Alssandri G, Ile Cristan G, Ziche M, Cappa APM, Gullino PM (1992) J Cell Physiol 151:23–28
Tai T, Kawashima I, Ozawa H, Kotani M, Ogura K (1997) Pure Appl Chem 69:1903–1910
Kracun I, Rosner H, Drnovsek V, Heffer-Lauc M, Cosovic C, Lauc G (1991) Int J Dev Biol 35:289–295
Schnaar RL, Needham LK (1994) Methods Enzymol 230:371–389
Zamfir A, Vukelic Ž, Bindila L, Almeida R, Sterling A, Allen M, Peter-Katalinic J (2004) J Am Soc Mass Spectrom 15:1649–1657
Vukelic Ž, Bognar SK, Froesch M, Bîndilă L, Radić B, Allen M, Peter Katalinić J, Zamfir AD (2007) Glycobiology 17:504–515
Vukelić Z, Zamfir AD, Bindila L, Froesch M, Peter-Katalinić J, Usuki S, Yu RK (2005) J Am Soc Mass Spectrom 16:571–580
Zamfir AD, Lion N, Vukelic Z, Bindila L, Rossier J, Girault HH, Peter-Katalinic J (2005) Lab Chip 5:298–307
Almeida R, Mosoarca C, Chirita M, Udrescu V, Dinca N, Vukelić Z, Allen M, Zamfir AD (2008) Anal Biochem 378:43–52
Serb A, Schiopu C, Flangea C, Vukelić Ž, Sisu E, Dinca N, Zagrean L, Zamfir AD (2009) Eur J Mass Spectrom 15:541–553
Zamfir AD, Vukelić Ž, Schneider A, Sisu E, Dinca N, Ingendoh A (2007) J Biomol Tech 18:188–193
Serb A, Schiopu C, Flangea C, Sisu E, Zamfir AD (2009) J Mass Spectrom in press
Svennerholm L, Fredman P (1980) Biochim Biophys Acta 617:97–109
Vukelić Ž, Metelmann W, Müthing J, Kos M, Peter-Katalinić J (2001) Biol Chem 382:259–274
Domon B, Costello CE (1988) Glycoconjugate J 5:397–409
Costello CE, Juhasz P, Perreault H (1994) Progr Brain Res 101:45–61
IUPAC-IUB Joint Commission on Biochemical Nomenclature (1998) Eur J Biochem 257:293–298
Saito M, Sugiyama K (2000) Biochim Biophys Acta 1474:88–92
Visnapuu T, Zamfir AD, Mosoarca C, Stanescu MD, Alamäe T (2009) Rapid Commun Mass Spectrom 23:1337–1346
Rouwendal GJ, Wuhrer M, Florack DE, Koeleman CA, Deelder AM, Bakker H, Stoopen GM, van Die I, Helsper JP, Hokke CH, Bosch D (2007) Glycobiology 17:334–344
Catalina MI, Koeleman CA, Deelder AM, Wuhrer M (2007) Rapid Commun Mass Spectrom 21:1053–1061
Wuhrer M, Koeleman CA, Deelder AM (2009) Anal Chem 81:4422–4432
Zeng G, Yu RK (2008) Curr Drug Targets 9:317–324
Acknowledgments
This work was supported by Romanian National Authority for Scientific Research through the PN-II-41001/2007 project. Permission for experiments with human tissue for scientific purposes was obtained from the Ethical Commission of “Victor Babes” University of Medicine and Pharmacy Timisoara and Zagreb Medical School, under the Project no. 108120 granted by the Croatian Ministry of Science and Technology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schiopu, C., Flangea, C., Capitan, F. et al. Determination of ganglioside composition and structure in human brain hemangioma by chip-based nanoelectrospray ionization tandem mass spectrometry. Anal Bioanal Chem 395, 2465–2477 (2009). https://doi.org/10.1007/s00216-009-3188-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-009-3188-8